Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
about
SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGYComparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the SensitiAntifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.One year prospective survey of Candida bloodstream infections in Scotland.Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from iraq and afghanistan.In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in CambodiaMulticenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.Molecular phylogenetics of Candida albicans.Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida sppUse of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species.The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.Evaluation of the relationship between the minimum inhibitory concentration of ceftiofur and third-generation cephalosporins in Escherichia coli isolates from food-producing animals.Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.Mutants with heteroresistance to amphotericin B and fluconazole in Candida.Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.EUCAST and CLSI: How to Assess in Vitro Susceptibility and Clinical Resistance
P2860
Q26783197-8683C9E0-2D9B-43BE-ACAA-9E81923692C9Q33827176-D32FD194-04A9-49C2-AA81-641355359D7FQ33903375-B4FB6B34-DA37-4891-9C40-D70BF9D1752BQ33910250-8EABB36F-D25C-445E-A2C2-B0EA1498C1D0Q35072030-446F2EBA-AFE6-478F-90FB-9AA94704CCCDQ35220825-A4FD9DF7-23D3-4B4A-A224-189345087CFDQ35690728-FD7493CF-9310-4495-8420-D81B3368777CQ35948286-AC6B1E0A-60EE-4F13-838B-C020F72390CAQ36314322-6B60FD13-6628-42F7-9291-29896DC405A0Q37644219-15F7B353-04B3-48BB-B1C3-7369B800AA54Q37700546-D5CE6AA5-ED7E-4A1C-A07F-8E6C2AB053BBQ38671171-5BEA1062-BB9E-40CA-BD22-DB24C4A109B4Q41872556-22B14736-9CE3-4C0E-B250-65B519E1D921Q42100410-A6645428-3EDA-41F4-BA32-693E2034B412Q42156902-A4591FDD-9A9C-4985-A59B-02292FFBEFA7Q46865944-6D225431-D070-40E2-8DA6-07D9E58C71C8Q57651693-4F82C9CE-5426-494A-9337-C78F242B7AF1
P2860
Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Correlation between the proced ...... nd four commercial techniques.
@en
Correlation between the proced ...... ibiotic Susceptibility Testing
@nl
type
label
Correlation between the proced ...... nd four commercial techniques.
@en
Correlation between the proced ...... ibiotic Susceptibility Testing
@nl
prefLabel
Correlation between the proced ...... nd four commercial techniques.
@en
Correlation between the proced ...... ibiotic Susceptibility Testing
@nl
P2093
P1476
Correlation between the proced ...... nd four commercial techniques.
@en
P2093
Cuenca-Estrella M
Gomez-Lopez A
Rodriguez-Tudela JL
P304
P356
10.1111/J.1469-0691.2005.01166.X
P577
2005-06-01T00:00:00Z